These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 9925787

  • 21. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor.
    Lindhout T, Franssen J, Willems G.
    Thromb Haemost; 1995 Sep; 74(3):910-5. PubMed ID: 8571320
    [Abstract] [Full Text] [Related]

  • 22. Peptide exosite inhibitors of factor VIIa as anticoagulants.
    Dennis MS, Eigenbrot C, Skelton NJ, Ultsch MH, Santell L, Dwyer MA, O'Connell MP, Lazarus RA.
    Nature; 2000 Mar 30; 404(6777):465-70. PubMed ID: 10761907
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
    Petersen LC, Sprecher CA, Foster DC, Blumberg H, Hamamoto T, Kisiel W.
    Biochemistry; 1996 Jan 09; 35(1):266-72. PubMed ID: 8555184
    [Abstract] [Full Text] [Related]

  • 26. High-resolution structure of bovine pancreatic trypsin inhibitor with altered binding loop sequence.
    Czapinska H, Otlewski J, Krzywda S, Sheldrick GM, Jaskólski M.
    J Mol Biol; 2000 Feb 04; 295(5):1237-49. PubMed ID: 10653700
    [Abstract] [Full Text] [Related]

  • 27. Structure-function relationship of serine protease-protein inhibitor interaction.
    Otlewski J, Jaskólski M, Buczek O, Cierpicki T, Czapińska H, Krowarsch D, Smalas AO, Stachowiak D, Szpineta A, Dadlez M.
    Acta Biochim Pol; 2001 Feb 04; 48(2):419-28. PubMed ID: 11732612
    [Abstract] [Full Text] [Related]

  • 28. Sequential coagulation factor VIIa domain binding to tissue factor.
    Osterlund M, Persson E, Carlsson U, Freskgård PO, Svensson M.
    Biochem Biophys Res Commun; 2005 Dec 02; 337(4):1276-82. PubMed ID: 16236263
    [Abstract] [Full Text] [Related]

  • 29. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
    Stone MD, Harvey SB, Martinez MB, Bach RR, Nelsestuen GL.
    Biochemistry; 2005 Apr 26; 44(16):6321-30. PubMed ID: 15835921
    [Abstract] [Full Text] [Related]

  • 30. Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathway.
    Osterlund M, Persson E, Svensson M, Carlsson U, Freskgård PO.
    Biochem Biophys Res Commun; 2005 Feb 18; 327(3):789-93. PubMed ID: 15649415
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Predicted solution structure of zymogen human coagulation FVII.
    Perera L, Darden TA, Pedersen LG.
    J Comput Chem; 2002 Jan 15; 23(1):35-47. PubMed ID: 11913388
    [Abstract] [Full Text] [Related]

  • 33. The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex.
    Kohrt JT, Filipski KJ, Cody WL, Cai C, Dudley DA, Van Huis CA, Willardsen JA, Rapundalo ST, Saiya-Cork K, Leadley RJ, Narasimhan L, Zhang E, Whitlow M, Adler M, McLean K, Chou YL, McKnight C, Arnaiz DO, Shaw KJ, Light DR, Edmunds JJ.
    Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4752-6. PubMed ID: 16125385
    [Abstract] [Full Text] [Related]

  • 34. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.
    Edgington TS, Mackman N, Fan ST, Ruf W.
    Nouv Rev Fr Hematol (1978); 1992 Nov 01; 34 Suppl():S15-27. PubMed ID: 1364116
    [Abstract] [Full Text] [Related]

  • 35. Regulation of the catalytic function of coagulation factor VIIa by a conformational linkage of surface residue Glu 154 to the active site.
    Shobe J, Dickinson CD, Ruf W.
    Biochemistry; 1999 Mar 02; 38(9):2745-51. PubMed ID: 10052945
    [Abstract] [Full Text] [Related]

  • 36. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
    Dickinson CD, Shobe J, Ruf W.
    J Mol Biol; 1998 Apr 10; 277(4):959-71. PubMed ID: 9545384
    [Abstract] [Full Text] [Related]

  • 37. The structural basis of function of the TF. VIIa complex in the cellular initiation of coagulation.
    Edgington TS, Dickinson CD, Ruf W.
    Thromb Haemost; 1997 Jul 10; 78(1):401-5. PubMed ID: 9198187
    [Abstract] [Full Text] [Related]

  • 38. Crystal structure of the extracellular region of human tissue factor.
    Harlos K, Martin DM, O'Brien DP, Jones EY, Stuart DI, Polikarpov I, Miller A, Tuddenham EG, Boys CW.
    Nature; 1994 Aug 25; 370(6491):662-6. PubMed ID: 8065454
    [Abstract] [Full Text] [Related]

  • 39. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
    Azim MK, Grossmann JG, Zaidi ZH.
    J Nat Toxins; 1999 Oct 25; 8(3):363-84. PubMed ID: 10591040
    [Abstract] [Full Text] [Related]

  • 40. Epitope location on tissue factor determines the anticoagulant potency of monoclonal anti-tissue factor antibodies.
    Kirchhofer D, Moran P, Chiang N, Kim J, Riederer MA, Eigenbrot C, Kelley RF.
    Thromb Haemost; 2000 Dec 25; 84(6):1072-81. PubMed ID: 11154116
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.